04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
Restaurant's Owner Sexually Harassed and Retaliated Against Female Employee, Federal Agency Charged ...
Read More >
The New Jersey Department of Labor (NJ DOL) billed Uber Technologies, Inc. and a subsidiary $650 mil...
Read More >
Welcome to the newest addition to the Compliance Podcast Network, Compliance and Coronavirus. In thi...
Read More >
On Tuesday, September 24, 2019, the United States Department of Labor (“Department”) announced its...
Read More >
The COVID-19 pandemic has caused a valuation gap between buyers and sellers in certain industries. A...
Read More >
Seyfarth Synopsis: In Flaherty v. Entergy Nuclear Operations, Inc., ___ F.3d ___, No. 18-1759, 2019 ...
Read More >